Two new trainings on the way! Thalocan Research Innovations is excited to announce that we are in the final stages of post-production on two new expert-led trainings; EASI – The Eczema Area and Severity Index and vIGA-AD – The Validated Investigator Global Assessment for Atopic Dermatitis. Both of these trainings are led by Jonathan…
Innovation. That’s what we’re about, too. Tomorrow, Thalocan Research Innovations CEO Eric Zudak begins four days at AAD innovation Academy 2026 – packed with the latest breakthroughs in dermatology, cutting-edge clinical insights and meaningful networking moments. Here at TRI we share this mindset of creating and sharing innovative and state-of-the-art technologies to assist physicians, trialists…
Thalocan Research Innovations CEO Eric Zudak is heading to New York City, July 16–19, for The 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology. The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. One breakthrough sure to be discussed is the enthusiastic response to our Lesion…
The Study That Changed Everything A Conversation with Teresa DeHaemerSenior Director of Business Strategy, Thalocan Research Innovations by Ginger Claremohr, Claremohr Writing Co. A single study changed the trajectory of Teresa DeHaemer’s career, but not in the way she might have expected. She was working in clinical psychology when she accepted a role supporting a…
